| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 850,7 k € | +106.2% | 412,6 k € | +0.8% | 409,3 k € | +18.1% | 346,5 k € | +20.4% | 287,8 k € | +149.8% | 115,2 k € | -11.4% | 130,0 k € | +23.9% | 104,9 k € | -18.5% | 128,6 k € | -16.2% | 153,6 k € | +19.3% | 128,7 k € | |
| EBITDA | 730,5 k € | +133.6% | 312,7 k € | -1.6% | 317,6 k € | +3.2% | 307,8 k € | +14.6% | 268,6 k € | +154.3% | 105,6 k € | +2.6% | 103,0 k € | +11.8% | 92,1 k € | -9.2% | 101,4 k € | -30.6% | 146,0 k € | +20.4% | 121,3 k € | |
| Operating profit | 534,7 k € | +164.6% | 202,1 k € | -6.6% | 216,5 k € | -2.0% | 221,0 k € | +23.2% | 179,4 k € | +3747.9% | 4,7 k € | -73.7% | 17,7 k € | +8.8% | 16,3 k € | -47.1% | 30,8 k € | -70.8% | 105,4 k € | +94.1% | 54,3 k € | |
| Profit/loss | 300,7 k € | +550.3% | 46,2 k € | -34.4% | 70,6 k € | -49.1% | 138,7 k € | +23.2% | 112,6 k € | +887.3% | -14,3 k € | -547.3% | -2,2 k € | +55.1% | -4,9 k € | -171.5% | -1,8 k € | -104.0% | 45,6 k € | +96.6% | 23,2 k € | |
| Equity | 720,6 k € | +71.6% | 419,8 k € | +12.4% | 373,6 k € | +23.3% | 303,0 k € | +84.4% | 164,3 k € | +217.5% | 51,8 k € | -21.6% | 66,1 k € | -3.2% | 68,3 k € | -6.7% | 73,2 k € | -2.4% | 75,0 k € | +155.2% | 29,4 k € | |
| Total assets | 3,0 M € | +10.3% | 2,7 M € | +11.2% | 2,5 M € | +87.2% | 1,3 M € | +54.5% | 854,9 k € | +16.2% | 735,9 k € | -4.1% | 767,6 k € | -6.7% | 822,8 k € | -2.7% | 845,4 k € | +13.1% | 747,6 k € | +7.9% | 693,0 k € | |
| Cash | 107,0 k € | +78.0% | 60,1 k € | -41.8% | 103,4 k € | +75.2% | 59,0 k € | -62.9% | 159,0 k € | +320.7% | 37,8 k € | -35.6% | 58,7 k € | +398.1% | 11,8 k € | -76.6% | 50,4 k € | -64.6% | 142,3 k € | +343.8% | 32,1 k € | |
| Debts | 2,3 M € | -1.4% | 2,3 M € | +11.1% | 2,1 M € | +106.3% | 1,0 M € | +47.4% | 689,1 k € | +1.0% | 682,6 k € | -2.5% | 699,9 k € | -7.2% | 754,5 k € | -2.3% | 772,2 k € | +15.1% | 671,1 k € | +1.4% | 662,1 k € | |
Private limited company · Charleroi · incorporated on 12/09/2013
Private limited company profitable and well capitalised. Cash position rising (+78.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
GESTIPHAR is a Private limited company incorporated in 2013. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Charleroi.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette